These effects, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the concept of concentrating on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Issues. Allows to lower chronic pain https://jimmyf359vsq3.blog-ezine.com/profile